Table 4.
A. Male | ≤ 94 cm | > 94 & ≤ 102 cm | > 102 cm | Total |
< 25 kg/m2 | 3.61 (3.78) [n = 1,800; 23.41%] | 5.84 (4.91) [n = 296; 3.85%] | 6.77 (4.63*) [n = 30; 0.39%] | 3.97 (4.0) [n = 2,126; 27.65%] |
≥ 25& < 30 kg/m2 | 4.56 (4.64) [n = 1,026; 13.34%] | 6.49 (5.49) [n = 1,564; 20.34%] | 7.68 (5.83) [n = 974; 12.67%] | 6.26 (5.35) [n = 3,564; 46.35%] |
≥ 30 kg/m2 | 6.15 (5.9*) [n = 28; 0.36%] | 6.07 (5.96) [n = 230; 2.99%] | 7.35 (6.18) [n = 1,742; 22.65%] | 7.19 (6.16) [n = 2,000; 26.01%] |
Total | 3.98 (4.12) [n = 2,854; 37.11%] | 6.35 (5.47) [n = 2,090; 27.18%) | 7.46 (6.05) [n = 2,746; 35.71%) | 5.87 (5.22) [7,690; 100.00%] |
B. Female | ≤ 80 cm | > 80 & ≤ 88 cm | > 88 cm | Total |
< 25 kg/m2 | 0.94 (1.08) [n = 2,438; 27.50%] | 1.35 (1.35) [n = 889; 10.03%] | 1.63 (1.62) [n = 223; 2.52%] | 1.09 (1.19) [n = 3,550; 40.05%] |
≥ 25& < 30 kg/m2 | 1.15 (1.23) [n = 360; 4.06%] | 1.43 (1.46) [n = 1,008; 11.37%] | 1.85 (1.75) [n = 1,566; 17.66%] | 1.62 (1.59) [n = 2,934; 33.10%] |
≥ 30 kg/m2 | 1.37 (1.29*) [n = 13; 0.15%] | 1.53 (1.5) [n = 96; 1.08%] | 1.86 (1.82) [n = 2,272; 25.63%] | 1.85 (1.81) [n = 2,381; 26.86%] |
Total | 0.97 (1.1) [n = 2,811; 31.71%] | 1.40 (1.41) [n = 1,993; 22.48%] | 1.85 (1.78) [n = 4,061; 45.81%] | 1.47 (1.5) [8865; 100.00%] |
[number of patients per patient group with non-missing PROCAM; proportion of all patients with non-missing PROCAM].
PROCAM risk in relation to BMI and waist circumference [12]. N means number of patients with non-missing PROCAM in each cell; % of inner 9 cells adds up to 100%; the figure displayed is the risk for cardiovascular events for the next 10 years calculated with the PROCAM score (standardized for age). Crude/age-standardized mean are reported. * means that the total N in this cell is 30 or below and therefore the direct age standardization may have led to unreliable results.